Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

PLA2G16 anticorps (AA 1-132) (FITC)

PLA2G16 Reactivité: Humain Hôte: Lapin Polyclonal FITC
N° du produit ABIN7155921
  • Antigène Voir toutes PLA2G16 Anticorps
    PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))
    Épitope
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 1-132
    Reactivité
    • 26
    • 3
    • 1
    Humain
    Hôte
    • 17
    • 7
    • 2
    Lapin
    Clonalité
    • 21
    • 5
    Polyclonal
    Conjugué
    • 17
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp PLA2G16 est conjugé à/à la FITC
    Application
    Veuillez nous consulter SVP
     Réactivité croisée
    Humain
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human HRAS-like suppressor 3 protein (1-132AA)
    Isotype
    IgG
    Top Product
    Discover our top product PLA2G16 Anticorps primaire
  • Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))
    Autre désignation
    PLA2G16 (PLA2G16 Produits)
    Synonymes
    anticorps HRASLS3, anticorps HREV107, anticorps HRSL3, anticorps AdPLA, anticorps H-REV107-1, anticorps HREV107-1, anticorps HREV107-3, anticorps C78643, anticorps Hrasls3, anticorps Hrev107, anticorps MLP-3, anticorps phospholipase A2 group XVI, anticorps phospholipase A2, group XVI, anticorps PLA2G16, anticorps Pla2g16
    Sujet

    Background: Exhibits PLA1/2 activity, catalyzing the calcium-independent hydrolysis of acyl groups in various phosphatidylcholines (PC) and phosphatidylethanolamine (PE). For most substrates, PLA1 activity is much higher than PLA2 activity. Specifically catalyzes the release of fatty acids from phospholipids in adipose tissue (By similarity). N- and O-acylation activity is hardly detectable. Might decrease protein phosphatase 2A (PP2A) activity.

    Aliases: Adipose specific phospholipase A2 antibody, Adipose specific PLA2 antibody, Adipose-specific phospholipase A2 antibody, AdPLA antibody, Ca independent phospholipase A1/2 antibody, Group XVI phospholipase A1/A2 antibody, Group XVI phospholipase A2 antibody, H rev 107 protein homolog antibody, H REV107 1 antibody, H-rev 107 protein homolog antibody, HRAS like suppressor 1 antibody, HRAS like suppressor 3 antibody, HRAS-like suppressor 1 antibody, HRAS-like suppressor 3 antibody, HREV107 1 antibody, HREV107 3 antibody, HREV107 antibody, HREV107-1 antibody, HREV107-3 antibody, HRSL3 antibody, HRSL3_HUMAN antibody, Phospholipase A2 group XVI antibody, Pla2g16 antibody, Renal carcinoma antigen NY REN 65 antibody, Renal carcinoma antigen NY-REN-65 antibody

    UniProt
    P53816
    Pathways
    Inositol Metabolic Process
Vous êtes ici: